Rapid Novor helps biotech and pharmaceutical companies extract the full potential of antibodies in ways never before possible. Thanks to our mass spectrometry and AI based protein sequencing, antibody discovery and antibody characterization services, researchers have furthered thousands of projects. We provide services and develop new technology that enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Our technology has the potential to unlock a new universe of discoveries that will shape future research, and benefit global health. At Rapid Novor, we believe that the journey to a world of more effective treatments that cost less and are easier to develop starts with decoding immunity.